Sebastian Aguiar is a geroscientist and Venture Fellow at Apollo Ventures. He believes that slowing and reversing the damage that causes aging will result in a medical paradigm shift equivalent to the advent of antibiotics.
Prior to Apollo, Sebastian was an Associate at Deep Knowledge Ventures in London, a Fulbright Research Fellow at the Telomere and Genomic Stability Laboratory of the Gulbenkian Institute, a VC finance research assistant at the California Institute of Technology (Caltech), and a SENS Research Scholar at the Buck Institute for Research on Aging. Sebastian holds an MSc in Biomedical Science from the University of Amsterdam where he was an Amsterdam Excellence Scholar. He also holds an MSc in Life Science Business Management from the VU Amsterdam and received his B.A. with honors in Human Biology from Pitzer College, Claremont University Consortium.